Jim Simons’s Oncorus, Inc. ONCR Stock Holding History

Jim Simons’s Portfolio ONCR Stock Details ONCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-144,000	Closed	-$50K	–	4405
2023 Q1	$50K	Sell	144,000 -142,936	-50%	-$53.3K	﹤0.01%	3669
2022 Q4	$73K	Buy	286,936 +77,403	+37%	+$44K	﹤0.01%	3710
2022 Q3	$178K	Sell	209,533 -7,917	-4%	-$10.2K	﹤0.01%	3419
2022 Q2	$274K	Buy	217,450 +41,918	+24%	+$56.9K	﹤0.01%	3511
2022 Q1	$312K	Buy	175,532 +161,432	+1,145%	+$452K	﹤0.01%	3456
2021 Q4	$74K	Sell	14,100 -15,971	-53%	-$124K	﹤0.01%	3735
2021 Q3	$281K	Buy	+30,071	New	+$343K	﹤0.01%	3102

Other funds holding ONCR

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

YAL

Your Advocates Ltd Houston, Texas $350M AUM 21.03% 1-Year Est. Return

Jim Simons's ONCR Position: Q2 2023 in Review

Jim Simons sold out of Oncorus, Inc. (ONCR) in Q2 2023, closing a stake of 144,000 shares — an estimated $50K sold.

Jim Simons first reported a position in ONCR in Q3 2021 and held it in 7 quarters. The position peaked at $312K in Q1 2022. 4 funds tracked by Wall St. Rank hold ONCR as of Q2 2023.

Jim Simons reported no remaining Oncorus, Inc. position as of Q2 2023 after selling out during the quarter.
Jim Simons sold 144,000 Oncorus, Inc. shares in Q2 2023, an estimated $50K.
Jim Simons first reported a position in Oncorus, Inc. in Q3 2021 and held it in 7 quarters.
Jim Simons's Oncorus, Inc. position peaked at $312K in Q1 2022.
4 funds tracked by Wall St. Rank held Oncorus, Inc. as of Q2 2023.

Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.